Extracellular activities of human granzyme A. Monocyte activation by granzyme A versus alpha-thrombin.
Granzymes, serine proteases located in the granules of cytotoxic T cel ls and NK cells, are essential for induction of target cell apoptosis. However, since cytotoxic cells constitutively secrete a portion of their synthesized granzymes, these proteases could mediate extracellular functions independent of their role in the lytic event. Thrombin, another serine protease, can induce cytokine production in a number of different cell types. In this study, we test the hypothesis that granzymes, like thrombin, can regulate cell-mediated immunity by inducing the production of different cytokines. We show that granzyme A (GA) stimulates IL-6, IL-8, and TNF-alpha production by human PBMC and purified monocytes. In contrast, monocytes exposed to thrombin had enhanced IL-8 production with no induction of IL-6 or TNF-alpha production. However, monocytes exposed to either GA or thrombin had enhanced phagocytic activity. The enzymatic activity of GA and thrombin was required for the induction of cytokine production and for the enhancement of phagocytic activity. The induction of different cytokine profiles by GA vs thrombin suggested that GA activates monocytes via a receptor that was different from the thrombin receptor. This conclusion was strengthened by the fact that GA was incapable of inducing Ca2+ mobilization in insect cells transfected with the thrombin receptor. These results suggest that enzymatically active GA mediates important immunoregulatory functions through signaling pathways that does not involve thrombin receptor activation.
Sower
L E
LE
Department of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, 77555, USA.
Froelich
C J
CJ
Allegretto
N
N
Rose
P M
PM
Hanna
W D
WD
Klimpel
G R
GR
D000818:Animals; D002460:Cell Line; D016207:Cytokines / Q000096:biosynthesis; D053804:Granzymes; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D066298:In Vitro Techniques; D015850:Interleukin-6 / Q000096:biosynthesis; D016209:Interleukin-8 / Q000096:biosynthesis; D009000:Monocytes / Q000187:drug effects / Q000201:enzymology* / Q000276:immunology*; D010587:Phagocytosis / Q000187:drug effects; D018179:Receptors, Thrombin / Q000235:genetics / Q000378:metabolism; D012697:Serine Endopeptidases / Q000378:metabolism* / Q000494:pharmacology*; D013917:Thrombin / Q000494:pharmacology*; D014162:Transfection; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
D016207:Cytokines; D015850:Interleukin-6; D016209:Interleukin-8; D018179:Receptors, Thrombin; D014409:Tumor Necrosis Factor-alpha; D053804:Granzymes; D012697:Serine Endopeptidases; D013917:Thrombin; C509212:GZMA protein, human